期刊文献+

脂肪因子内脂素与恶性肿瘤关系的研究现状及展望 被引量:11

The research advances in the relationship between visfatin and cancer
原文传递
导出
摘要 内脂素为脂肪细胞分泌的一种细胞因子,内脂素不仅在肥胖、糖尿病、胰岛素抵抗、动脉粥样硬化、多囊卵巢综合征等多种疾病中起重要作用,而且与代谢综合征相关性肿瘤,如乳腺癌、结肠癌、胃癌和子宫内膜癌等的发生、发展密切相关。内脂素抑制剂对肿瘤的生长具有一定抑制作用,有很好的临床应用前景。 Visfatin is a cytokine secreted by visceral adipose tissue, which plays an important role in obesity, diabetes, insulin resistance, atherosclerosis and polycystic ovarian syndrome. Additionally, visfatin is also involved in the metabolic syndrome-associated malignancies such as breast, colon, gastric and endometrial cancers. Visfatin inhibitor might be a potential antitumor therapeutic strategy for inhibiting the growth of many cancers.
出处 《中华肿瘤杂志》 CAS CSCD 北大核心 2017年第5期321-324,共4页 Chinese Journal of Oncology
基金 国家自然科学基金(81272863) 天津市卫生局科技基金(2015kz116)
关键词 内脂素 肿瘤 代谢综合征 内脂素抑制剂 生物标志物 Visfatin Neoplasms Metabolic syndrome Visfatin inhibitor Biomarker
  • 相关文献

参考文献2

二级参考文献37

  • 1Jemal A, Bray F, Center MM, et al. Global cancer statistics[ J]. CA Cancer J Clin, 2011,61 (2) :69-90.
  • 2Kamangar F, Dotes GM, Anderson WF. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world[J]. J Clin Oncol, 2006, 24(14) :2137-2150.
  • 3Pennathur A, Gibson MK, Jobe BA, et al. Oesophageal carcinoma[J]. Imcet, 2013, 381 (9864) :400-412.
  • 4Ryan AM, Duong M, Healy L, et al. Obesity, metabolic syndrome and esophageal adenocarcinoma: epidemiology, etiology and new targets [J]. Cancer Epidemiol, 2011, 35(4):309-319.
  • 5Kubo A, Codey DA. Body mass index and adenocarcinomas of the esophagus or gastric cardia: a systematic review and meta-analysis [ J ]. Cancer Epidemiol Biomarkers Prey, 2006,15 ( 5 ) :872-878.
  • 6Navarre Silvem SA, Mayne ST, Risch HA, et al. Principal component analysis of dietary and lifestyle patterns in relation to risk of subtypes of esophageal and gastric cancer [ J ]. Ann Epidemiol, 2011, 21 (7) :543-550.
  • 7Kavanagh ME, O'Sullivan KE, O'Hanlon C, et al. The esophagitis to adenocarcinoma sequence; the role of inflammation [ J ]. Cancer Lett, 2014, 345(2) :182-189.
  • 8Kendall B J, Macdonald GA, Hayward NK, et al. Leptin and the risk of Barrett's oesophagus[J]. Gut, 2008, 57(4) :448-454.
  • 9Rubenstein JH, Dahlkemper A, Kan JY, et al. A pilot study of the association of low plasma adiponectin and Barrett's esophagus [J]. Am J Gastreenterol, 2008, 103(6) :1358-1364.
  • 10Kato M, Watabe K, Hamasaki T, et al. Association of low serum adiponectin levels with erosive esophagitis in men: an analysis of 2405 subjects undergoing physical check-ups[J]. J Gastroenterol,2011,46(12):1361-1367.

共引文献16

同被引文献91

引证文献11

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部